HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 10171570, compound → HCID 10125445, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 10171570 | HCID 10171570 | — |
| Reactant | HCID 10193005 | HCID 10193005 | — |
| Reactant | HCID 10193093 | HCID 10193093 | — |
| Reactant | HCID 10236397 | HCID 10236397 | — |
| Reactant | HCID 10236419 | HCID 10236419 | — |
| Reactant | HCID 10236511 | HCID 10236511 | — |
| Product | HCID 10125445 | HCID 10125445 | — |
Reaction Steps
N,2-dicyclopropyl-6-(4,4-dimethyl-1-piperidinyl)-5-methyl-4-pyrimidinamine; N,2-dicyclopropyl-5-methyl-6-(4-methyl-1-piperidinyl)-4-pyrimidinamine; 6-(3-azabicyclo[3.2.1]oct-3-yl)-N,2-dicyclopropyl-5-methyl-4-pyrimidinamine; N,2-dicyclopropyl-5-methyl-6-(4-thiomorpholinyl)-4-pyrimidinamine; 4-azepan-1-yl-2-cyclopropyl-5,6,7,8-tetrahydro-pyrido[2,3-d]pyrimidine and 4-azepan-1-yl-2-cyclopropyl-6,7,8,9-tetrahydro-pyrimido[4,5-b]azepine, or pharmaceutically acceptable salts thereof.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07544675B2 |
| Source dataset | uspto-grants-2009_06 |
| ORD ID | ord-f754d61a29a740bb97ddd973c8af1a91 |
| Source note | uspto-grants-2009_06 |